NCT02207153View on ClinicalTrials.gov

Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Endstage Renal Disease
Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02207153 - Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients | Biotech Hunter | Biotech Hunter